Product Images Norethindrone And Ethinyl Estradiol And Ferrous Fumarate

The text describes Mortality Rate measured as the number of deaths per 100,000 woman users. It includes a graph (Figure 1) that represents the Circulatory Disease Mortality Rates per 100,000 women-years categorized by age, smoking status, and oral contraceptive use. The graph shows the mortality rates for Ever-Users (Nonsmokers), Ever-Users (Smokers), and controls (Nonsmokers and Smokers) in the age range of 15-24, 25-34, 35-44, and 45+.*

This is a description of a medication pack containing norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets 0.4 mg/35 mcg. The pack is divided into four weeks, with the first three weeks containing active tablets and the fourth week containing inactive tablets. There are labels for each day of the week and instructions on when to start the first pack of pills.*

This appears to be a medication label for a combination hormone contraceptive containing norethindrone and ethinyl estradiol with chewable and ferrous fumarate tablets. The label indicates a 4-week cycle of pills with the first three weeks being active pills and the fourth week containing inactive pills. The label also suggests to refer to specific instructions for starting the first pack of pills.*